Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions
{{output}}
Neuroendocrine tumors (NET) are frequently associated with glycemic disorders, such as prediabetes or diabetes, which may result from either surgical or medical treatments or hormonal hypersecretion by the tumor itself. Moreover, pre-existing diabetes is a kno... ...